Mylan Hit With Patent Suit Over Generic Nausea Drug
Heron Therapeutics has hit competitor Mylan Pharmaceuticals with a lawsuit in Delaware federal court claiming Mylan's plans for a generic nausea treatment infringe its patents....To view the full article, register now.
Already a subscriber? Click here to view full article